Indefinite Delivery Contract SPE2DB24D9212

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Illinois. The $499,999,999 single-award IDC, contract #SPE2DB24D9212, has a period of performance through December 31, 2025.

Under this IDC, DMS Pharmaceutical Group will provide a broad range of pharmaceutical products and medical supplies to support the medical needs of U.S. military facilities globally. Key product categories include injectable drugs like flumazenil and ampicillin, oral medications such as prednisone tablets, topical products including clotrimazole cream, and other medical consumables like surgical detergents and artificial tears. The IDC complements DMS Pharmaceutical Group's existing prime vendor contracts to directly distribute prescription drugs and provide pharmacy services to the Department of Defense. This IDC will enable the DLA to issue firm fixed-price delivery orders against the contract to fulfill recurring pharmaceutical requirements for military health facilities.